MARKET

CHEK

CHEK

Check Cap
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.440
0.000
0.00%
After Hours: 1.440 0 0.00% 19:39 03/02 EST
OPEN
1.470
PREV CLOSE
1.440
HIGH
1.550
LOW
1.420
VOLUME
2.80M
TURNOVER
--
52 WEEK HIGH
2.930
52 WEEK LOW
0.2430
MARKET CAP
66.58M
P/E (TTM)
-1.4215
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Are Penny Stocks Worth It? 4 Biotech Stocks To Watch This Week
Feb 24, 2021 (Penny Stocks via COMTEX) -- Penny Stocks To Watch Right Now As Biotech Industry Grows It can be difficult to know if the penny stocks on your...
Penny Stocks · 6d ago
Immunome, Avinger leads healthcare gainers; MEDNAX, ReWalk Robotics among major losers
Gainers: Immunome (IMNM) +93%, Avinger (AVGR) +33%, Titan Pharmaceuticals (TTNP) +17%, GBS (GBS) +15%, VistaGen Therapeutics (VTGN) +15%.Losers: MEDNAX (MD) -23%, ReWalk Robotics (RWLK) -21%, Shineco (TYHT) -19%, Check-Cap (CHEK) -15%, Advaxis (ADXS) -12%.
Seekingalpha · 02/18 16:01
AQMS, VIR, SOS and WBAI among premarket gainers
Comstock Mining (LODE +285% after buying stake in lithium-ion battery recycler.TDH Holdings (PETZ) +248%.Dogness (International) (DOGZ) +110%.Oncolytics Biotech (ONCY) +54%.ZW Data Action Technologies (CNET) +42%.China Xiangtai Food (PLIN) +41%.AirNet Tech...
Seekingalpha · 02/17 13:24
TLRY, GLUU, ABEO and TYME among premarket gainers
KalVista Pharmaceuticals (KALV) +207% on reporting positive results for KVD900.Comstock Holding Companies (CHCI) +163%.Applied UV (AUVI) +88% after acquiring Airocide Technology Platform.Heat Biologics (HTBX) +47% on announcing positive interim survival da...
Seekingalpha · 02/09 13:22
BRIEF-Check Cap Ltd Were Notified By Nasdaq That We Regained Compliance With Minimum $1 Bid Price Rule
reuters.com · 01/27 14:16
HTBX, TTOO among premarket losers
T2 Biosystems (TTOO) -20% despite strong Q4 & FY20 prelims.AIkido Pharma (AIKI) -18%.Seanergy Maritime Holdings (SHIP) -18%.Celsion CLSN -15%.Recon Technology (RCON) -15%.TransEnterix (TRXC) -14% after $69.25M capital raise.Ocugen (OCGN) -14%.BIOLASE (BIOL...
Seekingalpha · 01/27 13:35
Check-Cap Issues Letter to Shareholders
Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first and only patient-friendly preparation-free screening test to detect polyps before th...
PR Newswire · 01/27 13:30
Check-Cap Issues Letter to Shareholders
Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first and only patient-friendly preparation-free screening test to detect polyps before th...
PR Newswire · 01/27 13:30
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CHEK. Analyze the recent business situations of Check Cap through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average CHEK stock price target is 1.750 with a high estimate of 2.000 and a low estimate of 1.500.
EPS
Institutional Holdings
Institutions: 29
Institutional Holdings: 797.98K
% Owned: 1.73%
Shares Outstanding: 46.24M
TypeInstitutionsShares
Increased
0
0
New
8
371.35K
Decreased
3
57.78K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
-2.09%
Pharmaceuticals & Medical Research
-0.90%
Key Executives
Chairman/Director
Steven Hanley
Chief Executive Officer
Alex Ovadia
Chief Financial Officer
Mira Rosenzweig
Chief Technology Officer
Yoav Kimchy
Vice President - Operations
Joshua Belkar
Vice President
Israel Hershko
Vice President
Vardit Segal
Vice President - Research & Development
Boaz Shpigelman
Director
XiangQian Lin
Independent Director
Clara Ezed
Independent Director
Mary Jo Gorman
Independent Director
Yuval Yanai
  • Dividends
  • Splits
  • Insider Activity
No Data
About CHEK
Check-Cap is a Israel-based clinical-stage medical diagnostics company developing. The Company develops C-Scan, capsule-based, system ingestible imaging for colorectal cancer screening.

Webull offers kinds of Check Cap Ltd stock information, including NASDAQ:CHEK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CHEK stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CHEK stock methods without spending real money on the virtual paper trading platform.